Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
The First 90 Days of COVID-19: Lessons Learned
The emergence of COVID-19 marked the beginning of a public health crisis the scale of which we have never seen. Amid this unprecedented challenge, the pharmaceutical supply chain — powered by distributors — quickly adapted and adjusted to the global pandemic, protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients.
The Rx for Drug Shortages? A Better Understanding of the Supply Chain and Collaborative Solutions
As patients face challenges related to drug shortages, policymakers, regulators and healthcare supply chain leaders are engaged in ongoing discussions about mitigating threats and impact. In this piece, HDA's President and Chief Executive Officer Chip Davis explores some causes and solutions for drug shortages, and how distributors support a resilient supply chain through collaborative efforts and logistics expertise.
DSCSA 2023: Dispensers’ Role and Responsibilities
At HDA’s third Traceability Webinar on September 15, HDA’s Elizabeth Gallenagh, General Counsel and Senior Vice President, Supply Chain Integrity, spoke to Perry Fri, Executive Vice President, Industry Relations, Membership and Education, HDA; and Chief Operating Officer, HDA Research Foundation to dispel myths and offer clarity around the dispenser’s role and legal responsibilities per DSCSA requirements.
Americares Honors Boehringer Ingelheim with Power of Partnership Award
Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to the global biopharmaceutical company Boehringer Ingelheim, in recognition of its outstanding commitment to increasing access to medicines for patients in need around the globe.